Does a Series B medical device company need a fractional CRO in 2027?

Direct Answer

A fractional CRO can be a smart, cost-effective move for a Series B medical device company in 2027, but it's not a universal yes. Your stage—typically $3M-$15M ARR, with a small sales team and early product-market fit—means you likely need strategic revenue leadership without the full cost or commitment of a full-time executive. The key is whether your immediate need is to build a scalable sales process, navigate a complex regulatory sales cycle, and hire a VP of Sales, rather than just closing deals yourself. If your CEO is still the primary closer or your team lacks a repeatable playbook, a fractional CRO can provide that structure for 6-18 months.

Steps

Compare: Fractional CRO vs. Full-Time CRO

Why Series B Medical Device Companies Are a Unique Fit

Medical device companies at Series B face a distinct sales challenge that makes a fractional CRO particularly valuable. Your buyers are not typical SaaS decision-makers—they include surgeons, hospital administrators, procurement officers, and regulatory bodies. Sales cycles can stretch 12-18 months due to clinical evaluations, FDA or CE mark considerations, and multi-stakeholder approvals. A fractional CRO who has navigated this terrain can build a repeatable process without the company committing to a full-time executive who might not be needed after the scaling phase.

The cost structure is a major driver. A full-time CRO for a medical device company in a hub like Boston, Minneapolis, or the Bay Area commands a base salary of $250,000-$350,000 plus significant equity and benefits. For a Series B company burning cash on R&D and clinical trials, a fractional CRO at $8,000-$20,000 per month for 10-20 days of engagement is a fraction of that cost, freeing capital for product development and sales hiring.

What a Fractional CRO Actually Does for a Medical Device Company

A fractional CRO is not a part-time sales rep or a coach who just gives advice. They own revenue outcomes for the engagement period. For a Series B medical device company, this typically includes:

• Building a sales playbook tailored to your specific device, buyer personas, and regulatory environment. This includes territory planning, account selection, and qualification criteria.
• Hiring and training your first VP of Sales or sales team. They'll define job descriptions, interview candidates, and onboard them, then step back.
• Establishing a CRM and pipeline process using tools like Salesforce or HubSpot. They'll set up stages, metrics (e.g., conversion rates, average deal size), and forecasting cadences.
• Coaching your existing reps on medical device selling—handling objections from clinicians, navigating hospital procurement, and managing long sales cycles.
• Leading strategic deals with key accounts, often alongside the CEO, to close reference customers and build case studies.

They do not typically handle day-to-day administrative tasks, manage customer support, or run marketing campaigns unless explicitly scoped.

When a Fractional CRO Is a Bad Fit

There are scenarios where a fractional CRO is the wrong choice. If your company has less than $2M ARR and the CEO is still the primary closer, you likely need a full-time VP of Sales or a sales rep, not a strategic advisor. Similarly, if your product is still in early clinical trials and has no commercial traction, a fractional CRO can't fix a lack of product-market fit—you need a commercial launch strategist, not a revenue leader.

Another red flag: if your board expects a full-time, culture-building executive who will be in the office daily and manage a growing team, a fractional CRO may feel like a half-measure. Fractional CROs work best when the company is committed to hiring a full-time successor within 12-18 months. If you're looking for a permanent solution, hire a full-time CRO from the start.

How to Find and Vet a Fractional CRO for Medical Device

The best fractional CROs for medical device companies come from operational backgrounds in healthcare, life sciences, or medtech. They should have direct experience selling to hospitals, group purchasing organizations (GPOs), or specialty clinics—not just SaaS. Look for candidates who have been a VP of Sales or CRO at a medical device company, ideally at a similar stage.

Vetting questions to ask:

• "What is the longest sales cycle you've managed in medtech, and how did you shorten it?"
• "How do you handle hospital procurement and GPO contracts?"
• "Can you describe a time you built a sales team from scratch for a device launch?"
• "What metrics do you use to track pipeline health for a 12-month cycle?"

The Timeline and Exit Strategy

A typical fractional CRO engagement for a Series B medical device company lasts 6-18 months. The first 30-60 days are diagnostic: reviewing the current sales process, team, and pipeline. Months 3-6 focus on building the playbook, hiring key roles, and closing initial deals. Months 6-12 are about scaling the process and preparing for a full-time successor.

Your exit strategy should be defined upfront. Common triggers include hiring a full-time CRO or VP of Sales, hitting a revenue milestone (e.g., $10M ARR), or completing a product launch. The fractional CRO should actively help recruit and onboard their replacement—this is a sign of a good partner, not a threat to their engagement.

The Role of Tools and Data

A fractional CRO will likely want to use tools you may already have—Salesforce or HubSpot for CRM, Gong for call coaching, Clari for forecasting, and Outreach or Salesloft for sales engagement. They should not require you to adopt expensive new software unless it's critical. Expect them to audit your existing tech stack and recommend minimal changes to improve pipeline visibility.

Be wary of a fractional CRO who insists on a full tech overhaul in the first month. A good one will work with what you have, then suggest incremental upgrades as the team scales.

FAQ

What is the typical cost of a fractional CRO for a Series B medical device company? Costs range from $8,000 to $20,000 per month for 10-20 days of engagement, depending on the CRO's experience, your company's stage, and geographic location. Equity of 0.5%-2% is sometimes included. This is significantly less than a full-time CRO's total compensation of $300,000-$500,000+ annually.

How long does a fractional CRO engagement typically last? Most engagements run 6-18 months, with a clear exit plan to hire a full-time successor. Extensions are possible if the company isn't ready for a full-time hire.

Can a fractional CRO work remotely for a medical device company? Yes, most fractional CROs work hybrid or remote, especially if your company is not in a medtech hub like Boston, Minneapolis, or the Bay Area. They will travel for key meetings, customer visits, and team offsites.

What if my company is pre-revenue or has less than $1M ARR? A fractional CRO is likely premature. You need a full-time founder or VP of Sales to build the initial commercial engine. Focus on product-market fit and early clinical evidence first.

How do I ensure the fractional CRO is accountable for results? Define clear KPIs upfront: pipeline value, conversion rates, deals closed, and team hiring milestones. Tie a portion of their compensation to these metrics. Most fractional CROs work on a monthly retainer with a performance bonus.

Will a fractional CRO help me hire a full-time CRO later? A good fractional CRO will actively help recruit and onboard their replacement. This is a standard part of the engagement—they want to leave the company better than they found it.

Sources

• Join Pavilion - Revenue Leadership Community
• RevOps Co-op - Revenue Operations Community
• Harvard Business Review - Sales and Marketing Articles
• First Round Review - Startup Leadership
• SaaStr - B2B SaaS Growth Insights
• LinkedIn - Fractional Executive Groups

People also search for: fractional cro · hire a fractional cro · fractional cro near me · fractional cro cost